New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CI;WCG;HNT;MOH;UNH;CVH;WLP;AGP;CNC;HS;HUM;AET;MDT;BSX;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
July 27, 2015
13:24 EDTCI, AET, HUMRegulators to consider 'too big to fail' in health insurance reviews, CTFN says
Subscribe for More Information
10:00 EDTCI, CNCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ADT Corp. (ADT) upgraded to Buy from Neutral at Citi... AGCO (AGCO) upgraded to Neutral from Sell at Goldman... Anthem (ANTM) upgraded to Buy from Neutral at Sterne Agee CRT... BNP Paribas (BNPQY) upgraded to Buy from Neutral at Goldman... Biogen (BIIB) upgraded on valuation at Bernstein... Box (BOX) upgraded to Overweight from Sector Weight at Pacific Crest... Capital One (COF) upgraded to Buy from Outperform at CLSA... Centene (CNC) upgraded to Buy from Neutral at UBS... Chesapeake (CHK) upgraded on potential sale of assets or company at SunTrust... Cigna (CI) upgraded to Buy from Neutral at Sterne Agee CRT... Deere (DE) upgraded to Neutral from Sell at Goldman... First BanCorp (FBP) upgraded to Buy from Neutral at Guggenheim... Flotek (FTK) upgraded on stronger demand at Oppenheimer... Lear (LEA) upgraded to Buy from Hold at Deutsche Bank... Methanex (MEOH) upgraded to Outperform from Sector Perform at Scotia Howard Weil... News Corp. (NWSA) upgraded to Outperform from Neutral at Macquarie... NextEra Energy Partners (NEP) upgraded to Outperform at Wells Fargo... OFG Bancorp (OFG) upgraded to Buy from Neutral at Guggenheim... PennyMac Mortgage (PMT) upgraded to Buy from Neutral at Compass Point... Pool Corp. (POOL) upgraded to Outperform from Market Perform at William Blair... Popular (BPOP) upgraded to Buy from Neutral at Guggenheim... Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley... Quality Systems (QSII) upgraded on valuation at RBC Capital... VF Corp. (VFC) upgraded to Buy from Neutral at Goldman... Ventas (VTR) upgraded on valuation, positive catalysts at BMO Capital... Weatherford (WFT) upgraded to Equal Weight from Underweight at Barclays... SS&C (SSNC) upgraded to Buy from Hold at Sandler O'Neill... Chemung Financial (CHMG) upgraded to Buy from Hold at Sandler O'Neill... Cameron (CAM) upgraded to Buy from Accumulate at Global Hunter.
08:10 EDTHUM, AET, CILeerink sees at least 60% chance of Anthem, Cigna deal being approved
Subscribe for More Information
07:33 EDTCNCCentene upgraded to Buy from Neutral at UBS
UBS upgraded Centene to Buy from Neutral citing recent share weakness, its strong pipeline and other underappreciated opportunities. UBS maintained its $80 price target on Centene shares.
06:53 EDTCICigna upgraded to Buy from Neutral at Sterne Agee CRT
Subscribe for More Information
July 26, 2015
18:22 EDTAET, HUM, CIMedia reports say Teva to buy Allergan unit as it looks beyond Mylan
Subscribe for More Information
July 24, 2015
17:12 EDTCIAnthem a Buy even if Cigna deal falls through, Barron's reports
Subscribe for More Information
16:30 EDTCI, STJStocks end week lower as Apple headlines busy week of earnings
Subscribe for More Information
16:22 EDTCIOn The Fly: Top stock stories for Friday
Subscribe for More Information
12:54 EDTCIOn The Fly: Top stock stories at midday
Subscribe for More Information
09:12 EDTCIAnthem says 'fully committed' to overcoming integration challenges
Subscribe for More Information
08:51 EDTCIAnthem expects to suspend buyback program for remainder of 2015
Subscribe for More Information
07:50 EDTCIAnthem and Cigna to hold a joint conference call
Subscribe for More Information
07:31 EDTCICigna volatility elevated into Anthem acquiring for $54.2B
Cigna (CI) August call option implied volatility is at 28, September is at 23; compared to its 52-week range of 18 to 38, suggesting large price movement into Anthem (ANTM) acquiring Cigna for $103.40 in cash and 0.5152 Anthem common shares for each Cigna common share.
07:21 EDTCIAnthem volatility elevated into acquiring Cigna for $54.2B
Subscribe for More Information
06:30 EDTCIAnthem, Cigna see deal closing in 2H16
Subscribe for More Information
06:07 EDTCICigna sees FY15 EPS $8.30-$8.60, consensus $8.53
Subscribe for More Information
06:05 EDTCICigna reports preliminary Q2 adjusted EPS $2.50, consensus $2.25
Subscribe for More Information
06:04 EDTCIAnthem sees Cigna transactoin to achieve EPS accretion approaching 10% in year 1
Subscribe for More Information
06:03 EDTCIAnthem agrees to acquire Cigna for transaction valued at $54.2B
Anthem (ANTM) and Cigna (CI) announced that they have entered into a definitive agreement whereby Anthem will acquire all outstanding shares of Cigna in a cash and stock transaction and Cigna shareholders will receive $103.40 in cash and 0.5152 Anthem common shares for each Cigna common share. The total per share consideration equates to approximately $188.00 for each Cigna share based on Anthem's closing share price on May 28, 2015, valuing the transaction at $54.2 billion on an enterprise basis. Following the transaction, Anthem will have more than $115B in pro forma annual revenues, based on the most recent 2015 outlooks publicly reported by both companies and will gain meaningful diversification covering approximately 53M medical members with well positioned commercial, government, consumer, specialty and international franchises. Upon the close of the transaction, Joseph Swedish will serve as Chairman and CEO of the combined company and David Cordani will be President and COO. In addition, effective upon closing, the Anthem board of Directors will be expanded to 14 members. David Cordani and four independent directors from Cignaís current board will join the nine current members of the Anthem board. The transaction is expected to close in the second half of 2016, pending the receipt of customary approvals, including certain state regulatory approvals and expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. In addition, the transaction is subject to customary closing conditions, including the approval of Cignaís shareholders of the merger agreement and Anthemís shareholders of the issuance of shares in the transaction. Anthem is confident in its ability to obtain all necessary regulatory and other approvals. The combined company expects to achieve adjusted earnings per share accretion approaching 10% in year one, with the accretion more than doubling by year two following the closing of the transaction. We are confident in our ability to achieve synergy targets and are committed to retaining investment grade debt ratings. Anthem expects its debt-to-capital ratio to be approximately 49% at the time of close, with a plan to bring the ratio down to the low 40% range within 24 months. Anthem has received committed financing from Bank of America, Credit Suisse and UBS Investment Bank in connection with the transaction.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use